Maurice Joseph Anthony Clancy

Title: Maurice Joseph Anthony Clancy: Innovator in Pediatric Pharmaceutical Formulations

Introduction

Maurice Joseph Anthony Clancy is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of pediatric formulations. With a total of 5 patents to his name, Clancy's work focuses on improving the efficacy and safety of medications for children.

Latest Patents

Clancy's latest patents include innovative pediatric suspension formulations. These formulations involve storage-stable proton pump inhibitor (PPI) systems that contain a therapeutically effective amount of a PPI, such as omeprazole. The formulations are designed to be constituted with water prior to administration, ensuring stability and effectiveness. Additionally, they include oral pharmaceutical suspensions that comprise water, a PPI, and one or more buffering agents, enhancing the overall therapeutic profile for pediatric patients.

Career Highlights

Throughout his career, Clancy has worked with prominent companies in the pharmaceutical industry. Notable among these are Alkermes Pharma Ireland Limited and Xeolas Pharmaceuticals Ltd. His experience in these organizations has allowed him to develop and refine his innovative approaches to pediatric medications.

Collaborations

Clancy has collaborated with esteemed professionals in the field, including Rajeev A Jain and Janet Elizabeth Codd. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Maurice Joseph Anthony Clancy stands out as a dedicated inventor in the pharmaceutical industry, particularly in the realm of pediatric formulations. His innovative work continues to impact the health and well-being of children, making significant strides in medication safety and efficacy.